Constraint-induced Movement Therapy for Perinatal Brachial Plexus Injury

NCT ID: NCT03765034

Last Updated: 2018-12-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-01

Study Completion Date

2014-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study evaluates the addition of constraint-induced movement therapy (CIMT) to usual care occupational therapy in children with perinatal brachial plexus injury. Participants are randomized to receive either the intervention (CIMT) or control first, then cross over to receive the other one.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Children with perinatal brachial plexus injury routinely receive occupational therapy intervention to improve strength and function in their weak or paralyzed arm.

Constraint-induced movement therapy (CIMT) is known to increase upper extremity function in children with weakness or disuse as a result of cerebral palsy. However, it is unknown if this therapy is effective for treating arm weakness or disuse as a result of perinatal brachial plexus injury. The addition of CIMT to usual and standard occupational therapy care is evaluated in this trial.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neonatal Brachial Plexus Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Constraint-induced Movement Therapy

A passive constraint cast is applied to the participant's unaffected arm to prevent use for 8 weeks.

Group Type EXPERIMENTAL

Constrain-induced Movement Therapy

Intervention Type BEHAVIORAL

8-week therapy program utilizing constraint of the unaffected arm

Usual Occupational Therapy

Intervention Type BEHAVIORAL

8-week therapy program without constraint of the unaffected arm

Usual Occupational Therapy

Usual and standard care occupational therapy is administered for 8 weeks.

Group Type ACTIVE_COMPARATOR

Usual Occupational Therapy

Intervention Type BEHAVIORAL

8-week therapy program without constraint of the unaffected arm

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Constrain-induced Movement Therapy

8-week therapy program utilizing constraint of the unaffected arm

Intervention Type BEHAVIORAL

Usual Occupational Therapy

8-week therapy program without constraint of the unaffected arm

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participant has perinatal brachial plexus injury
* Participant walking at time of study inception
* Ability to cooperate with interventions and assessment
* Participant currently receiving occupational therapy 1+ hour per week and planning to continue for duration of study

Exclusion Criteria

* Co-morbid diagnosis not related to perinatal brachial plexus injury
* Flaccidity of the involved upper extremity or no observable hand function
* Planned surgery or drug intervention during the study period
* Allergy or intolerance to constraint intervention materials
Minimum Eligible Age

12 Months

Maximum Eligible Age

5 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Children's Hospital Los Angeles

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

julie werner

Clinical Scientist

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CCI-10-00255

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pully System Exercise Role in Management of Spasticity
NCT06927869 ENROLLING_BY_INVITATION NA
CIMT and taVNS for Hemiplegia in Infants
NCT05101707 COMPLETED EARLY_PHASE1
NMES Efficacy on Patients With NBPP
NCT01999465 COMPLETED NA